6-K/A XBRL

AMENDMENT TO FORM 6-K

Company: Altamira Therapeutics Ltd.
Filed: September 17, 2020
Period of Report: June 30, 2020
Accession Number: 0001213900-20-027077

View Document ↗ View on SEC.gov ↗